Bronchial reactivity to inhaled hypertonic saline solutions in children with cystic fibrosis
Background. Inhaled hypertonic saline solutions (IHSS) are included in the list of mandatory prescriptions in the treatment of cystic fibrosis (CF). However, some patients with CF may develop bronchial hyperreactivity (BHR), which may be the cause of violation of the treatment protocol. The purpose...
Furkejuvvon:
Váldodahkkit: | S.I. Ilchenko (Dahkki), A.O. Fialkovska (Dahkki), K.V. Skriabinа (Dahkki), S.G. Ivanus (Dahkki) |
---|---|
Materiálatiipa: | Girji |
Almmustuhtton: |
Zaslavsky O.Yu.,
2022-09-01T00:00:00Z.
|
Fáttát: | |
Liŋkkat: | Connect to this object online. |
Fáddágilkorat: |
Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|
Geahča maid
-
Predicting the tolerability of inhalation therapy as a stage of a personalized approach in the treatment of children with cystic fibrosis
Dahkki: K.V. Skriabinа, et al.
Almmustuhtton: (2023) -
Analysis of the structure and antibiotic resistance of etiologically significant pathogens of chronic lower respiratory tract infection in children with cystic fibrosis living in Dnipro
Dahkki: S.I. Ilchenko, et al.
Almmustuhtton: (2020) -
Hypertonic saline in people with cystic fibrosis: review of comparative studies and clinical practice
Dahkki: Vito Terlizzi, et al.
Almmustuhtton: (2021) -
The cost-effectiveness of hypertonic saline inhalations for infant bronchiolitis
Dahkki: Jefferson Antonio Buendía, et al.
Almmustuhtton: (2020) -
Effects of inhaled hypertonic (7%) saline on lung function test in preschool children with cystic fibrosis: results of a crossover, randomized clinical trial
Dahkki: Raffaella Nenna, et al.
Almmustuhtton: (2017)